Mini-webinar: Can cystatin C eGFR improve accuracy in kidney care?

14. Dec 2023 | 5 min read

Mini-webinar: Can cystatin C eGFR improve accuracy in kidney care?

In the series of mini-webinars on cystatin C and kidney health our Global Product Manager for Cystatin C Mr. Gaute Tangen focuses on cystatin C eGFR as a potential enhancer of accuracy and reliability of estimating kidney function.

The biomarker cystatin C

Cystatin C is produced at a constant rate and freely filtered by the kidneys. The biomarker is less influenced by factors like age, gender or muscle mass compared to creatinine. Therefore, using cystatin C, combined with or instead of creatinine, might offer a more accurate estimations of kidney function, particularly in populations where testing with creatinine can be less reliable.

Research and studies conducted by the European Kidney Function Consortium (EKFC) and other groups have explored the utility of cystatin C as a biomarker for kidney function estimation without the inclusion of race and sex. By integrating cystatin C into the EKFC equation for estimating GFR, there's a potential for heightened accuracy.

Watch webinar: Can cystatin C eGFR improve accuracy in kidney care?

In this short webinar we will look into an article focusing on estimation of GFR without inclusion of race and sex that are published in The New England Journal of Medicine:
Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex

 

 

Watch on YouTube

 

Cystatin C in European Kidney Function Consortium (EKFC) equation

The European Kidney Function Consortium (EKFC) developed the creatinine-based equation (EKFC eGFRcr) to estimate GFR in the early 2000s. The creatinine-based equation aimed to standardise the estimation of GFR by adjusting the serum creatinine level to account for variations related to age, sex, or race.

Resent research conducted across cohorts from Europe, the United States, and Africa demonstrates that the newly developed cystatin C-based equation (EKFC eGFRcys) shows improved accuracy in assessing GFR compared to commonly used equations. The advantage of this equation stemmed from cystatin C's properties as a biomarker less influenced by factors like age, sex, or muscle mass, making it potentially more reliable in estimating kidney function across diverse populations.

 

Contact Gentian - Cystatin C

Get in touch with our Product Manager for cystatin C for product specification and pricing. Fill out the form below or send an email to marketing@gentian.com

 

Previous mini-webinars

 

Cystatin C, Creatinine and eGFR Equations

Disparities in kidney care

 

 

 

 

 

 

 
This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances.

CE bw

 

 

You may also read


Meet Gentian and explore circulating calprotectin at CORA 2025

Feb 27, 2025

Meet Gentian and explore circulating calprotectin at CORA 2025

We are excited to announce that Gentian will be exhibiting at CORA 2025, the Congress on Controversies in..

Gentian at #MVC2025: Advancing veterinary diagnostics with canine CRP

Feb 14, 2025

Gentian at #MVC2025: Advancing veterinary diagnostics with canine CRP

Connect with us @ Midwest Veterinary Conference and discover canine CRP Gentian Diagnostics is excited to..

Circulating calprotectin in paediatrics: Benefits and clinical applications

Feb 05, 2025

Circulating calprotectin in paediatrics: Benefits and clinical applications

Calprotectin - Emerging biomarker for multiple paediatric diseases Calprotectin, a calcium-binding protein..